PAK1 deficiency leads to cardiac hypertrophy and increased risk of mortality related to heart failure, and PAK1 or PAK2 activation may be beneficial in hypertrophy and heart failure [15–20]. Here, PAK2 is linked to cardiac hypertrophy.